Fletcher Payne
2018
In 2018, Fletcher Payne earned a total compensation of $969.5K as Chief Financial Officer at Catalyst Biosciences, a 24% increase compared to previous year.
Compensation breakdown
| Bonus | $120,855 |
|---|---|
| Option Awards | $501,228 |
| Salary | $345,301 |
| Other | $2,092 |
| Total | $969,476 |
Payne received $501.2K in option awards, accounting for 52% of the total pay in 2018.
Payne also received $120.9K in bonus, $345.3K in salary and $2.1K in other compensation.
Rankings
In 2018, Fletcher Payne's compensation ranked 9,346th out of 14,244 executives tracked by ExecPay. In other words, Payne earned more than 34.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,346 out of 14,244 | 34th |
Division Manufacturing | 3,742 out of 5,765 | 35th |
Major group Chemicals And Allied Products | 1,406 out of 2,128 | 34th |
Industry group Drugs | 1,183 out of 1,817 | 35th |
Industry Pharmaceutical Preparations | 913 out of 1,391 | 34th |
Source: SEC filing on May 2, 2019.
Payne's colleagues
We found two more compensation records of executives who worked with Fletcher Payne at Catalyst Biosciences in 2018.